Toll Free: 1-888-928-9744

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024

Published: Feb 29, 2016 | Pages: 64 | Publisher: GlobalData | Industry: Pharmaceutical | Report Format: Electronic (PDF)

Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings of emotional highs (mania or hypomania) and lows (depression). In between episodes of mood swings, patients typically return to their regular state of being. During a manic or depressive episode, the disease can be debilitating, severely affecting a person's ability to perform on the job or maintain good relationships with other people.

In 2014, there were 13,808,283 12-month and 23,140,488 lifetime total prevalent cases of bipolar disorder in the 8MM. In 2014, of the lifetime total prevalent cases, 52.15% were cyclothymic disorder, 24.58% bipolar I, and 23.27% bipolar II. GlobalData epidemiologists forecast that there will be approximately 14,703,622 12-month and 24,616,577 lifetime total prevalent cases of bipolar disorder in 2024.

In this report, GlobalData epidemiologists provide the forecast for the 12-month and lifetime total prevalent cases (both diagnosed and undiagnosed) of bipolar disorder spectrum in the 8MM. GlobalData epidemiologists sourced robust data based on national and international epidemiological studies and strong regional level studies. Age- and sex-specific rates were used whenever available. GlobalData epidemiologists used a consistent disease definition as well as consistent forecast methodology across all the 8MM to allow for a meaningful comparison among them.

Scope

The Bipolar EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for bipolar spectrum disorder in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year epidemiological forecast for both 12-month and lifetime total prevalent cases of bipolar I, bipolar II, and cyclothymic disorder segmented by sex and age in these markets.
The bipolar epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Bipolar EpiCast report will allow you to -

Develop business strategies by understanding the trends shaping and driving the global bipolar market.
Quantify patient populations in the global bipolar market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for bipolar therapeutics in each of the markets covered.
Identify the subtype of bipolar disorder spectrum most important to your market plans.
 Table of Contents

1. Table of Contents
1.1. List of Tables
1.2. List of Figures

2. Introduction
2.1. Catalyst
2.2. Related Reports
2.3. Upcoming Related Reports

3. Epidemiology
3.1. Disease Background
3.2. Risk Factors and Comorbidities
3.3. Global Trends
3.4. Forecast Methodology
3.4.1. Sources Used
3.4.2. Sources Not Used
3.4.3. Forecast Assumptions and Methods
3.5. Epidemiological Forecast of Bipolar Disorder (2014-2024)
3.5.1. 12-Month Total Prevalent Cases of Bipolar Spectrum Disorder
3.5.2. 12-Month Total Prevalent Cases of Bipolar I
3.5.3. 12-Month Total Prevalent Cases of Bipolar II
3.5.4. 12-Month Total Prevalent Cases of Cyclothymic Disorder
3.5.5. Lifetime Total Prevalent Cases of Bipolar Spectrum Disorder
3.5.6. Age-Specific 12-Month Total Prevalent Cases of Bipolar I
3.5.7. Age-Specific 12-Month Total Prevalent Cases of Bipolar II
3.5.8. Age-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder
3.5.9. Sex-Specific 12-Month Total Prevalent Cases of Bipolar I
3.5.10. Sex-Specific 12-Month Total Prevalent Cases of Bipolar II
3.5.11. Sex-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder
3.5.12. Age-Standardized 12-Month Total Prevalence of Bipolar Spectrum Disorder
3.6. Discussion
3.6.1. Epidemiological Forecast Insight
3.6.2. Limitations of the Analysis
3.6.3. Strengths of the Analysis

4. Appendix
4.1. Bibliography
4.2. Physicians and Specialists Included in this Study
4.3. About the Authors
4.3.1. Epidemiologists
4.3.2. Reviewers
4.3.3. Global Director of Therapy Analysis and Epidemiology
4.3.4. Global Head of Healthcare
4.4. About GlobalData
4.5. About EpiCast
4.6. Disclaimer
List of Tables

Table 1: Risk Factors and Comorbidities for Bipolar Disorder
Table 2: 8MM, Sources Used to Forecast the 12-Month Total Prevalent Cases of Bipolar Disorder I
Table 3: 8MM, Sources Used to Forecast the Lifetime Total Prevalent Cases of Bipolar Disorder I
Table 4: 8MM, Sources Used to Forecast the 12-Month Total Prevalent Cases of Bipolar Disorder II
Table 5: 8MM, Sources Used to Forecast the Lifetime Total Prevalent Cases of Bipolar Disorder II
Table 6: 8MM, Sources Used to Forecast 12-Month Total Prevalent Cases of Cyclothymic Disorder
Table 7: 8MM, Sources Used to Forecast Lifetime Total Prevalent Cases of Cyclothymic Disorder
Table 8: 8MM, 12-Month Total Prevalent Cases of Bipolar Spectrum Disorder Summary, Both Sexes, Ages ≥13 Years, N (Row %), 2014
Table 9: 8MM, 12-Month Total Prevalent Cases of Bipolar I, Both Sexes, Ages ≥13 Years, 2014-2024
Table 10: 8MM, 12-Month Total Prevalent Cases of Bipolar II, Both Sexes, Ages ≥13 Years, 2014-2024
Table 11: 8MM, 12-Month Total Prevalent Cases of Cyclothymic Disorder, Both Sexes, Ages ≥13 Years, 2014-2024
Table 12: 8MM, Lifetime Total Prevalent Cases of Bipolar Spectrum Disorder Summary, Both Sexes, Ages ≥13 Years, N (Row %), 2014
Table 13: 8MM, Age-Specific 12-Month Total Prevalent Cases of Bipolar I, Both Sexes, Ages ≥13 Years, N (Row %), 2014
Table 14: 8MM, Age-Specific 12-Month Total Prevalent Cases of Bipolar II, Both Sexes, Ages ≥13 Years, N (Row %), 2014
Table 15: 8MM, Age-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder, Both Sexes, Ages ≥13 Years, N (Row %), 2014
Table 16: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Bipolar I, Ages ≥13 Years, N (Row %), 2014
Table 17: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Bipolar II, Ages ≥13 Years, N (Row %), 2014
Table 18: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder, Ages ≥13 Years, N (Row %), 2014
Table 19: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country 


List of Figures

Figure 1: 8MM, 12-Month Total Prevalent Cases of Bipolar I, Both Sexes, Ages ≥13 Years, 2014-2024
Figure 2: 8MM, Bipolar II 12-Month Total Prevalent Cases, Both Sexes, Ages ≥13 Years, 2014-2024
Figure 3: 8MM, 12-Month Total Prevalent Cases of Cyclothymic Disorder, Both Sexes, Ages ≥13 Years, 2014-2024
Figure 4: 8MM, Age-Specific 12-Month Total Prevalent Cases of Bipolar I, Both Sexes, 2014
Figure 5: 8MM, Age-Specific 12-Month Total Prevalent Cases of Bipolar II, Both Sexes, 2014
Figure 6: 8MM, Age-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder, Both Sexes, 2014
Figure 7: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Bipolar I, Ages ≥13 Years, 2014
Figure 8: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Bipolar II, Ages ≥13 Years, 2014
Figure 9: 8MM, Sex-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder, Ages ≥13 Years, 2014
Figure 10: 8MM, Age-Standardized 12-Month Total Prevalence of Bipolar Spectrum Disorder, Men, Ages ≥13 Years, 2014
Figure 11: 8MM, Age-Standardized 12-Month Total Prevalence of Bipolar Spectrum Disorder, Women, Ages ≥13 Years, 2014

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $3995
Multi User - US $7990
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify